Pharvaris N.V.

PHVS

$35.66

+1.39%

N/A+$0.49

Healthcare

Biotechnology

NASDAQ

Active Trading

Pharvaris N.V., a late-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases with unmet needs covering angioedema ...

Financial Highlights of PHVS

Profitability trend

Latest / TTM · 6 periods

Gross Margin

0.0%

Net Margin

0.0%

P/E Ratio

-11.36x

n/a

Debt / Equity

0.00

n/a

Current Ratio

11.94

Dividend Yield

0.0%

Understanding

TTM —

Interest coverage is weak

Financial highlights

Latest / TTM · 6 periods

Snapshot

Latest / TTM: 2026-09-04

Gross Margin

0.0%

Net Margin

0.0%

P/E Ratio

-11.36x

Debt / Equity

0.00

Profitability

Profitability table

Metric	2021	2022	2023	2024	2025	2026
Gross MarginGross profit as a percentage of revenue.	0.0%	0.0%	0.0%	0.0%	0.0%	—
Operating MarginOperating income as a percentage of revenue.	0.0%	0.0%	0.0%	0.0%	0.0%	—
Net MarginNet income as a percentage of revenue.	0.0%	0.0%	0.0%	0.0%	0.0%	—
EBITDA MarginEBITDA divided by revenue.	0.0%	0.0%	0.0%	0.0%	0.0%	—
Pre-tax MarginPre-tax profit as a percentage of revenue.	0.0%	0.0%	0.0%	0.0%	0.0%	—

Liquidity & leverage

Liquidity & leverage table

Metric	2021	2022	2023	2024	2025	2026
Current RatioCurrent assets divided by current liabilities.	30.28	9.16	27.25	12.60	10.11	—
Quick RatioLiquid assets divided by current liabilities.	30.28	8.93	27.25	12.60	10.11	—
Cash RatioCash and equivalents divided by current liabilities.	29.97	8.88	26.79	12.22	9.85	—
Debt / AssetsDebt as a share of total assets.	0.1%	0.3%	0.1%	0.3%	0.3%	—
Debt / EquityDebt compared with shareholder equity.	0.00	0.00	0.00	0.00	0.00	—

Operating efficiency

Operating efficiency table

Metric	2021	2022	2023	2024	2025	2026
Receivables TurnoverHow often receivables are collected in a year.	0.00x	0.00x	0.00x	0.00x	0.00x	—
Inventory TurnoverHow often inventory is sold in a year.	0.00x	0.00x	0.00x	0.00x	0.00x	—
Payables TurnoverHow often payables are paid in a year.	0.00x	0.00x	0.00x	0.00x	0.00x	—
Asset TurnoverRevenue generated per dollar of assets.	0.00x	0.00x	0.00x	0.00x	0.00x	—
Working Capital TurnoverRevenue generated per dollar of working capital.	0.00x	0.00x	0.00x	0.00x	0.00x	—

Valuation ratios

Valuation ratios table

Metric	2021	2022	2023	2024	2025	2026
P/E RatioPrice paid for each dollar of earnings.	-8.97x	-4.63x	-9.65x	-7.46x	-7.95x	—
P/B RatioPrice paid for each dollar of book value.	1.88x	2.36x	2.54x	3.73x	5.15x	—
P/S RatioPrice paid for each dollar of sales.	0.00x	0.00x	0.00x	0.00x	0.00x	—
P/FCF RatioPrice paid for each dollar of free cash flow.	-8.60x	-5.24x	-10.46x	-8.29x	-10.18x	—
Dividend YieldAnnual dividend divided by current share price.	0.0%	0.0%	0.0%	0.0%	0.0%	—

About UsPrivacy PolicyTerms of ServiceDisclaimerStock DirectoryETFsIndices13F HoldingsAnalyst TargetsFree ToolsTechnology MapJoin our Slack

Plutux is not an investment adviser. Market data and AI-generated analysis are for information and education only, not investment advice. Disclaimer